Physician profile
Eric K Davis
NPI 1942363130
$1,382.18
in general payments reported to CMS, 2019-2025
17 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $61.75 · 2021: $85.96 · 2022: $135 · 2023: $215 · 2024: $374 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $265.73 | 2019-2025 | |
| Janssen Biotech, INC. | $256.87 | 2019-2024 | Stelara, Tremfya |
| Novartis Pharmaceuticals Corporation | $153.81 | 2019-2024 | |
| Lilly USA, LLC | $148.87 | 2022-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $143.89 | 2019-2025 | |
| Exact Sciences Corporation | $65.25 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $58.08 | 2019-2025 | |
| Abbott Laboratories | $42.90 | 2021-2022 | |
| Averitas Pharma INC. | $41.86 | 2025 | Qutenza |
| Novo Nordisk INC | $41.48 | 2021-2025 | Wegovy |
| Sunovion Pharmaceuticals INC. | $35.81 | 2019 | |
| Vanda Pharmaceuticals INC. | $28.37 | 2019 | |
| Allergan, INC. | $25.52 | 2019-2020 | |
| Sanofi Pasteur INC. | $21.99 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $21.33 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $17.24 | 2019 | |
| Amarin Pharma, INC. | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.